These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11535006

  • 1. Vascular endothelial growth factor in chronic subdural haematomas.
    Shono T, Inamura T, Morioka T, Matsumoto K, Suzuki SO, Ikezaki K, Iwaki T, Fukui M.
    J Clin Neurosci; 2001 Sep; 8(5):411-5. PubMed ID: 11535006
    [Abstract] [Full Text] [Related]

  • 2. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T, Tanji N, Sato K, Fujita H, Nishio S, Sakanaka M, Yokoyama M.
    Anticancer Res; 2001 Sep; 21(1A):77-88. PubMed ID: 11299793
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Sep; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 4. Possible role of cyclooxygenase-2 in developing chronic subdural hematoma.
    Hara M, Tamaki M, Aoyagi M, Ohno K.
    J Med Dent Sci; 2009 Sep; 56(3):101-6. PubMed ID: 20099472
    [Abstract] [Full Text] [Related]

  • 5. Angiogenic protein expression in advanced epithelial ovarian cancer.
    Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S.
    Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
    [Abstract] [Full Text] [Related]

  • 6. Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization.
    Fukuzawa M, Sugiura H, Koshinaga T, Ikeda T, Hagiwara N, Sawada T.
    J Pediatr Surg; 2002 Dec; 37(12):1747-50. PubMed ID: 12483647
    [Abstract] [Full Text] [Related]

  • 7. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A, Kantarjian HM, Estey EH, Giles FJ, Verstovsek S, Manshouri T, Gidel C, O'Brien S, Keating MJ, Albitar M.
    Cancer; 2002 Nov 01; 95(9):1923-30. PubMed ID: 12404286
    [Abstract] [Full Text] [Related]

  • 8. Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease.
    Weigel R, Schilling L, Schmiedek P.
    Acta Neurochir (Wien); 2001 Aug 01; 143(8):811-8; discussion 819. PubMed ID: 11678402
    [Abstract] [Full Text] [Related]

  • 9. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan 01; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 10. [Study of the changes and effect of VEGF and bFGF in early stage of maxillofacial blast injury in rabbits].
    Zhang C, Li H, Zhou S, Yang J.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Apr 01; 19(2):77-9, 82. PubMed ID: 12539415
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and soluble interleukin-2 receptor (sIL-2R) concentrations in peripheral blood as markers of pituitary tumours.
    Komorowski J, Jankewicz J, Stepień H.
    Cytobios; 2000 Apr 01; 101(398):151-9. PubMed ID: 10755214
    [Abstract] [Full Text] [Related]

  • 12. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H, Li Y, Zhu G, Zhang L, Zhang X, He X.
    Zhonghua Yi Xue Za Zhi; 2002 May 25; 82(10):708-11. PubMed ID: 12133473
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The peritoneal cavity is a distinct compartment of angiogenic molecular mediators.
    Nachtsheim R, Dudley B, McNeil PL, Howdieshell TR.
    J Surg Res; 2006 Jul 25; 134(1):28-35. PubMed ID: 16650862
    [Abstract] [Full Text] [Related]

  • 17. Angiopoietins, growth factors, and vascular morphology in early arthritis.
    Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ.
    J Rheumatol; 2003 Feb 25; 30(2):260-8. PubMed ID: 12563678
    [Abstract] [Full Text] [Related]

  • 18. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, Huber J, Nakatani T, Tsujinoue H, Yanase K, Imazu H, Fukui H.
    Hepatology; 2002 Apr 25; 35(4):834-42. PubMed ID: 11915029
    [Abstract] [Full Text] [Related]

  • 19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 25; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 20. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct 25; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.